Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial
Natasha Thorn, Zsofia Danos, Nick Andrews, Natalina Sutton et autres
gb (code pays fourni par la source)